BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20659559)

  • 21. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells.
    Lin WL; Liang WH; Lee YJ; Chuang SK; Tseng TH
    Chem Biol Interact; 2010 Dec; 188(3):607-15. PubMed ID: 20836997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
    Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs.
    Chen Y; Aulia S; Li L; Tang BL
    Brain Res Rev; 2006 Aug; 51(2):265-74. PubMed ID: 16414120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lingo-1 inhibited by RNA interference promotes functional recovery of experimental autoimmune encephalomyelitis.
    Wang CJ; Qu CQ; Zhang J; Fu PC; Guo SG; Tang RH
    Anat Rec (Hoboken); 2014 Dec; 297(12):2356-63. PubMed ID: 25045138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the low-affinity neurotrophin receptor, p75(NTR), is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination.
    Petratos S; Gonzales MF; Azari MF; Marriott M; Minichiello RA; Shipham KA; Profyris C; Nicolaou A; Boyle K; Cheema SS; Kilpatrick TJ
    Glia; 2004 Oct; 48(1):64-75. PubMed ID: 15326616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination.
    Lee X; Yang Z; Shao Z; Rosenberg SS; Levesque M; Pepinsky RB; Qiu M; Miller RH; Chan JR; Mi S
    J Neurosci; 2007 Jan; 27(1):220-5. PubMed ID: 17202489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNK1 is involved in Nogo66 inhibition of OPC differentiation.
    Zhang ZH; Li JJ; Wang QJ; Zhao WQ; Hong J; Lou SJ; Xu XH
    Mol Cell Neurosci; 2015 Mar; 65():135-42. PubMed ID: 25749374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats.
    Mann SA; Versmold B; Marx R; Stahlhofen S; Dietzel ID; Heumann R; Berger R
    J Neuroinflammation; 2008 Sep; 5():39. PubMed ID: 18808689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes.
    Du Y; Fischer TZ; Clinton-Luke P; Lercher LD; Dreyfus CF
    Mol Cell Neurosci; 2006 Feb; 31(2):366-75. PubMed ID: 16356734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities.
    Diolaiti D; Bernardoni R; Trazzi S; Papa A; Porro A; Bono F; Herbert JM; Perini G; Della Valle G
    Exp Cell Res; 2007 Aug; 313(14):2980-92. PubMed ID: 17619016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes.
    Roth AD; Leisewitz AV; Jung JE; Cassina P; Barbeito L; Inestrosa NC; Bronfman M
    J Neurosci Res; 2003 May; 72(4):425-35. PubMed ID: 12704804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.
    Kwon HS; Nakaya N; Abu-Asab M; Kim HS; Tomarev SI
    J Neurosci; 2014 Apr; 34(16):5539-51. PubMed ID: 24741044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINGO-1 negatively regulates TrkB phosphorylation after ocular hypertension.
    Fu QL; Hu B; Li X; Shao Z; Shi JB; Wu W; So KF; Mi S
    Eur J Neurosci; 2010 Mar; 31(6):1091-7. PubMed ID: 20377621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic expression of p75
    Wang L; Yu C; Sun X; Chan SO
    Neurosci Lett; 2018 Nov; 686():106-111. PubMed ID: 30201307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence.
    Rudick RA; Mi S; Sandrock AW
    Expert Opin Biol Ther; 2008 Oct; 8(10):1561-70. PubMed ID: 18774923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invivo insulin deficiency as a potential etiology for demyelinating disease.
    Gong X; Xie Z; Zuo H
    Med Hypotheses; 2008 Sep; 71(3):399-403. PubMed ID: 18621485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of complement messenger RNAs and proteins by human oligodendroglial cells.
    Hosokawa M; Klegeris A; Maguire J; McGeer PL
    Glia; 2003 Jun; 42(4):417-23. PubMed ID: 12730962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy.
    Stoica G; Lungu G; Kim HT; Wong PK
    Brain Res; 2008 May; 1208():204-16. PubMed ID: 18395188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sp1 phosphorylation is involved in myelin basic protein gene transcription.
    Guo L; Eviatar-Ribak T; Miskimins R
    J Neurosci Res; 2010 Nov; 88(15):3233-42. PubMed ID: 20882567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial inhibition of the proteasome enhances the activity of the myelin basic protein promoter.
    Calatayud CA; GarcĂ­a CI; Paez PM; Pasquini JM; Soto EF; Pasquini LA
    Dev Neurosci; 2009; 31(3):169-80. PubMed ID: 19145069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.